Asthika Goonewardene
Stock Analyst at Truist Securities
(2.01)
# 3,083
Out of 5,135 analysts
88
Total ratings
39.53%
Success rate
-7.13%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Asthika Goonewardene
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Initiates: Buy | $40 | $22.91 | +74.60% | 1 | Dec 17, 2025 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $43 | $23.25 | +84.95% | 1 | Nov 25, 2025 | |
| GMAB Genmab | Reiterates: Buy | $49 → $48 | $29.16 | +64.61% | 16 | Nov 7, 2025 | |
| GILD Gilead Sciences | Reiterates: Buy | $127 → $145 | $152.74 | -5.07% | 3 | Nov 3, 2025 | |
| RCUS Arcus Biosciences | Reiterates: Buy | $32 → $39 | $19.43 | +100.72% | 2 | Oct 7, 2025 | |
| JANX Janux Therapeutics | Initiates: Buy | $100 | $13.21 | +657.00% | 1 | Sep 10, 2025 | |
| RVMD Revolution Medicines | Initiates: Buy | $99 | $99.79 | -0.79% | 1 | Sep 5, 2025 | |
| EXEL Exelixis | Maintains: Buy | $56 → $49 | $44.47 | +10.19% | 11 | Jul 29, 2025 | |
| BNTX BioNTech SE | Reiterates: Buy | $151 → $155 | $107.95 | +43.58% | 3 | Jun 3, 2025 | |
| LEGN Legend Biotech | Maintains: Buy | $88 → $71 | $18.35 | +286.92% | 2 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $10 | $2.27 | +340.53% | 7 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $1.56 | +541.03% | 4 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $15 | $2.72 | +451.47% | 6 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $15.88 | +120.40% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $136 | $69.04 | +96.99% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $150 | $17.43 | +760.59% | 6 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.71 | +134.60% | 5 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 | $1.62 | +1,072.84% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $432 | $7.06 | +6,018.98% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Hold | $120 | $8.88 | +1,251.35% | 1 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $100 → $60 | $1.48 | +3,954.05% | 3 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $228 → $180 | $12.94 | +1,291.04% | 4 | Aug 23, 2022 |
Zymeworks
Dec 17, 2025
Initiates: Buy
Price Target: $40
Current: $22.91
Upside: +74.60%
ArriVent BioPharma
Nov 25, 2025
Initiates: Buy
Price Target: $43
Current: $23.25
Upside: +84.95%
Genmab
Nov 7, 2025
Reiterates: Buy
Price Target: $49 → $48
Current: $29.16
Upside: +64.61%
Gilead Sciences
Nov 3, 2025
Reiterates: Buy
Price Target: $127 → $145
Current: $152.74
Upside: -5.07%
Arcus Biosciences
Oct 7, 2025
Reiterates: Buy
Price Target: $32 → $39
Current: $19.43
Upside: +100.72%
Janux Therapeutics
Sep 10, 2025
Initiates: Buy
Price Target: $100
Current: $13.21
Upside: +657.00%
Revolution Medicines
Sep 5, 2025
Initiates: Buy
Price Target: $99
Current: $99.79
Upside: -0.79%
Exelixis
Jul 29, 2025
Maintains: Buy
Price Target: $56 → $49
Current: $44.47
Upside: +10.19%
BioNTech SE
Jun 3, 2025
Reiterates: Buy
Price Target: $151 → $155
Current: $107.95
Upside: +43.58%
Legend Biotech
May 14, 2025
Maintains: Buy
Price Target: $88 → $71
Current: $18.35
Upside: +286.92%
May 14, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $2.27
Upside: +340.53%
Apr 1, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $1.56
Upside: +541.03%
Mar 3, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $2.72
Upside: +451.47%
Jan 8, 2025
Initiates: Buy
Price Target: $35
Current: $15.88
Upside: +120.40%
Nov 12, 2024
Maintains: Buy
Price Target: $87 → $136
Current: $69.04
Upside: +96.99%
Aug 16, 2024
Maintains: Buy
Price Target: $180 → $150
Current: $17.43
Upside: +760.59%
May 21, 2024
Maintains: Buy
Price Target: $5 → $4
Current: $1.71
Upside: +134.60%
May 16, 2024
Maintains: Buy
Price Target: $19
Current: $1.62
Upside: +1,072.84%
Sep 6, 2023
Reiterates: Buy
Price Target: $432
Current: $7.06
Upside: +6,018.98%
Apr 5, 2023
Reinstates: Hold
Price Target: $120
Current: $8.88
Upside: +1,251.35%
Aug 23, 2022
Maintains: Hold
Price Target: $100 → $60
Current: $1.48
Upside: +3,954.05%
Aug 23, 2022
Maintains: Buy
Price Target: $228 → $180
Current: $12.94
Upside: +1,291.04%